Gujarat Themis Biosyn, 506879, GUJTHEM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,175.00
89.44
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,328.78
0.17%
14.51

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.54
10.74
0.54

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.57
11.29
-1.34

PAT CAGR (%)

10 Years
5 Years
3 Years

26.55
10.07
-5.60

P:E (Median)

8 Years
5 Years
3 Years

17.98
28.03
63.39

P:BV (Average)

8 Years
5 Years
3 Years

10.13
11.18
13.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.80
30.31
42.29

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 44.23 37.74 17.20% 43.37 39.52 9.74% 42.35 34.72 21.98% 35.87 38.83 -7.62%
Expenses 24.87 21.70 14.61% 22.06 20.65 6.83% 21.41 19.32 10.82% 21.95 20.28 8.23%
EBITDA 19.36 16.04 20.70% 21.31 18.87 12.93% 20.94 15.39 36.06% 13.92 18.55 -24.96%
EBIDTM 43.77% 42.50% 49.13% 47.74% 49.46% 44.33% 38.81% 47.78%
Other Income 0.92 1.35 -31.85% 0.42 0.24 75.00% 0.82 0.32 156.25% 0.27 0.52 -48.08%
Interest 1.91 0.07 2,628.57% 0.96 0.14 585.71% 0.04 0.08 -50.00% 0.04 0.07 -42.86%
Depreciation 4.04 1.23 228.46% 3.89 1.56 149.36% 2.96 1.44 105.56% 2.03 1.15 76.52%
PBT 14.34 16.09 -10.88% 16.87 17.40 -3.05% 18.76 14.19 32.21% 12.12 17.86 -32.14%
Tax 3.45 4.09 -15.65% 4.41 4.43 -0.45% 4.50 3.63 23.97% 3.06 4.62 -33.77%
PAT 10.89 12.00 -9.25% 12.46 12.97 -3.93% 14.27 10.57 35.00% 9.06 13.24 -31.57%
PATM 24.62% 31.79% 28.74% 32.83% 33.68% 30.44% 25.26% 34.09%
EPS 1.00 1.10 -9.09% 1.14 1.19 -4.20% 1.31 0.97 35.05% 0.83 1.21 -31.40%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 165.82 150.80 169.82 148.39 114.85 90.56 85.12 41.05 38.80 35.69 32.62 Net Sales Growth 9.95% -11.20% 14.44% 29.20% 26.82% 6.39% 107.36% 5.80% 8.71% 9.41% Cost Of Goods Sold 21.40 23.22 35.72 25.77 16.10 15.13 11.05 1.04 2.15 1.48 0.32 Gross Profit 144.42 127.58 134.10 122.61 98.75 75.43 74.07 40.01 36.65 34.21 32.30 GP Margin 87.10% 84.60% 78.97% 82.63% 85.98% 83.29% 87.02% 97.47% 94.46% 95.85% 99.02% Total Expenditure 90.29 81.96 91.09 74.76 56.81 50.23 53.29 33.69 32.56 29.64 26.59 Power & Fuel Cost - 26.63 26.53 26.41 21.73 16.57 22.86 20.20 19.33 17.99 17.15 % Of Sales - 17.66% 15.62% 17.80% 18.92% 18.30% 26.86% 49.21% 49.82% 50.41% 52.58% Employee Cost - 11.44 10.21 7.75 7.08 7.11 6.43 5.17 4.46 4.42 4.28 % Of Sales - 7.59% 6.01% 5.22% 6.16% 7.85% 7.55% 12.59% 11.49% 12.38% 13.12% Manufacturing Exp. - 12.95 13.64 10.62 9.00 9.35 10.97 5.67 5.01 4.43 3.58 % Of Sales - 8.59% 8.03% 7.16% 7.84% 10.32% 12.89% 13.81% 12.91% 12.41% 10.97% General & Admin Exp. - 4.98 4.02 2.53 1.43 1.16 0.93 0.95 0.95 0.76 0.77 % Of Sales - 3.30% 2.37% 1.70% 1.25% 1.28% 1.09% 2.31% 2.45% 2.13% 2.36% Selling & Distn. Exp. - 0.27 0.42 1.04 0.31 0.38 0.54 0.32 0.03 0.03 0.00 % Of Sales - 0.18% 0.25% 0.70% 0.27% 0.42% 0.63% 0.78% 0.08% 0.08% 0% Miscellaneous Exp. - 2.46 0.53 0.64 1.15 0.53 0.49 0.35 0.64 0.53 0.00 % Of Sales - 1.63% 0.31% 0.43% 1.00% 0.59% 0.58% 0.85% 1.65% 1.49% 1.50% EBITDA 75.53 68.84 78.73 73.63 58.04 40.33 31.83 7.36 6.24 6.05 6.03 EBITDA Margin 45.55% 45.65% 46.36% 49.62% 50.54% 44.53% 37.39% 17.93% 16.08% 16.95% 18.49% Other Income 2.43 2.43 4.37 6.59 4.05 3.27 1.70 2.21 0.17 0.36 0.17 Interest 2.95 0.36 0.23 0.18 0.83 0.98 0.92 0.16 0.42 0.41 0.38 Depreciation 12.92 5.37 3.54 2.58 2.23 1.73 1.36 1.22 1.15 1.12 1.20 PBT 62.09 65.54 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 Tax 15.42 16.77 20.17 19.50 15.41 10.70 7.58 1.79 0.97 0.51 0.00 Tax Rate 24.83% 25.59% 25.43% 25.17% 26.11% 26.17% 24.25% 21.83% 20.04% 10.45% 0.00% PAT 46.68 48.77 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 PAT before Minority Interest 46.68 48.77 59.16 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 28.15% 32.34% 34.84% 39.07% 37.98% 33.33% 27.81% 15.62% 9.97% 12.27% 14.19% PAT Growth -4.31% -17.56% 2.05% 32.90% 44.53% 27.50% 269.27% 65.63% -11.64% -5.40% EPS 4.28 4.47 5.43 5.32 4.00 2.77 2.17 0.59 0.36 0.40 0.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 248.38 201.38 149.15 103.32 69.95 42.20 18.52 12.11 8.21 3.84 Share Capital 10.90 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 Total Reserves 237.49 194.11 141.88 96.06 62.68 34.93 11.26 4.85 0.95 -3.42 Non-Current Liabilities 32.37 3.58 1.90 2.02 2.49 4.54 1.43 0.46 1.32 1.52 Secured Loans 29.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 1.05 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 3.18 0.00 0.00 0.40 0.00 Long Term Provisions 0.77 0.69 0.60 0.58 0.51 0.49 0.51 0.46 0.55 0.47 Current Liabilities 37.26 36.20 35.70 31.67 25.87 24.29 12.81 7.92 11.90 9.32 Trade Payables 14.65 9.91 9.54 6.62 3.54 7.45 5.60 5.58 7.14 5.51 Other Current Liabilities 5.63 5.94 4.94 8.60 10.87 9.16 7.13 2.28 3.56 3.63 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 1.14 0.10 Short Term Provisions 16.98 20.35 21.22 16.45 11.46 7.69 0.08 0.06 0.06 0.08 Total Liabilities 318.01 241.16 186.75 137.01 98.31 71.03 32.76 20.49 21.43 14.68 Net Block 41.29 38.02 32.66 19.43 18.95 17.08 14.61 10.59 10.63 9.37 Gross Block 59.33 51.21 44.04 28.24 25.52 21.93 18.10 12.86 11.75 41.61 Accumulated Depreciation 18.04 13.19 11.38 8.81 6.57 4.85 3.49 2.27 1.12 32.24 Non Current Assets 249.34 173.55 104.60 44.11 24.94 34.94 24.72 12.65 13.18 11.47 Capital Work in Progress 184.41 91.22 20.59 12.70 2.07 0.36 0.95 0.17 0.20 0.04 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 Long Term Loans & Adv. 22.26 9.92 9.81 2.77 2.61 2.38 2.45 1.62 2.08 1.74 Other Non Current Assets 1.39 34.39 41.53 9.21 1.31 15.12 6.71 0.27 0.27 0.32 Current Assets 68.67 67.60 82.15 92.90 73.37 36.08 8.04 7.84 8.25 3.21 Current Investments 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 Inventories 5.05 3.33 14.62 11.61 6.05 6.03 0.34 0.46 0.51 0.42 Sundry Debtors 31.24 27.03 17.91 25.12 14.71 20.23 5.80 2.72 6.99 2.16 Cash & Bank 12.55 8.16 9.33 12.35 27.64 2.08 1.70 4.46 0.41 0.19 Other Current Assets 19.84 0.93 1.37 1.76 24.96 7.74 0.20 0.20 0.35 0.44 Short Term Loans & Adv. 19.47 28.16 38.93 42.06 22.98 7.44 0.05 0.06 0.21 0.32 Net Current Assets 31.41 31.40 46.45 61.23 47.50 11.80 -4.77 -0.08 -3.65 -6.11 Total Assets 318.01 241.15 186.75 137.01 98.31 71.02 32.76 20.49 21.43 14.68

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 91.03 64.21 39.48 40.31 10.53 0.63 0.69 5.59 2.80 3.91 PBT 65.54 79.33 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 Adjustment 5.09 0.46 -2.45 0.15 -0.24 0.65 -3.92 1.44 1.48 1.58 Changes in Working Capital 36.88 4.19 -15.11 -4.36 -19.98 -24.30 -2.45 -0.11 -2.94 -1.70 Cash after chg. in Working capital 107.51 83.99 59.90 54.83 20.66 7.60 1.83 6.17 3.43 4.51 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.49 -19.78 -20.42 -14.52 -10.13 -6.97 -1.14 -0.59 -0.63 -0.52 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 Cash From Investing Activity -111.82 -55.21 -20.41 -29.83 -2.25 -2.98 -5.75 -1.03 -2.51 -0.78 Net Fixed Assets -101.31 -77.80 -23.69 -13.35 -5.30 -3.24 -6.02 -1.08 29.70 -0.86 Net Investments 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 Others -10.51 22.59 3.28 -16.48 3.04 0.26 0.27 0.05 -32.21 0.08 Cash from Financing Activity 26.01 -8.59 -13.27 -14.00 -5.16 2.10 5.29 -3.80 -0.19 -3.15 Net Cash Inflow / Outflow 5.22 0.41 5.79 -3.51 3.12 -0.26 0.23 0.76 0.10 -0.01 Opening Cash & Equivalents 6.47 6.05 0.26 3.97 0.86 1.12 0.89 0.13 0.03 0.04 Closing Cash & Equivalent 11.69 6.47 6.05 0.46 3.97 0.86 1.12 0.89 0.13 0.03

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 22.79 18.48 13.69 14.22 48.14 29.04 12.75 8.34 5.65 2.65 ROA 17.44% 27.65% 35.81% 37.08% 35.65% 45.62% 24.07% 18.45% 24.25% 31.50% ROE 21.69% 33.76% 45.92% 50.35% 53.82% 77.99% 41.85% 38.06% 72.63% 302.71% ROCE 27.48% 45.40% 61.51% 67.91% 67.89% 85.96% 44.88% 42.22% 54.67% 80.38% Fixed Asset Turnover 2.73 3.57 4.11 4.27 3.82 4.25 2.65 3.15 1.34 0.79 Receivable days 70.51 48.29 52.91 63.29 70.42 55.80 37.88 45.67 46.80 25.38 Inventory Days 10.13 19.29 32.26 28.06 24.34 13.65 3.55 4.57 4.73 4.19 Payable days 193.03 99.37 114.42 115.10 132.50 42.12 60.55 72.03 77.99 76.35 Cash Conversion Cycle -112.39 -31.80 -29.25 -23.75 -37.74 27.33 -19.12 -21.79 -26.47 -46.78 Total Debt/Equity 0.12 0.00 0.00 0.00 0.04 0.19 0.32 0.05 0.49 0.86 Interest Cover 181.05 347.14 440.64 72.31 42.66 34.85 52.71 12.59 12.96 13.26

Top Investors:

quant mutual fund - quant manufacturing fund

ayushmat ltd

llp

Annual Reports:

News Update:

Guj. Themis Biosyn - Quarterly Results
26th May 2026, 00:00 AM

Read More
Gujarat Themis Biosyn signs definitive agreement to acquire MicroBiopharm Japan Co
23rd May 2026, 10:48 AM

The transaction is expected to close during Q2FY27, subject to customary approvals and closing formalities
Read More
Gujarat Themis Biosyn to acquire Sanofi’s anti TB, anti-infective brands
24th Apr 2026, 09:11 AM

The consideration for the transaction would be 158 million euro
Read More

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

BSE: 506879 | NSE: GUJTHEM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

BSE: 506879 | NSE: GUJTHEM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: